News
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
WINTER SPRINGS, Fla., March 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...
IRADIMED CORPORATION Issues Urgent Medical Device Correction
Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter SetWINTER SPRINGS, Fla., Feb. 24, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Directors approved a special...
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
WINTER SPRINGS, Fla., Jan. 26, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market opens on Thursday, February 2, 2023. IRADIMED management will host a conference call...
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced selected preliminary financial...
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER SPRINGS, Fla., Nov. 03, 2022 -- IRADIMED CORPORATION (the "Company")...
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
WINTER SPRINGS, Fla., Oct. 27, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3rd. IRADIMED management will host a conference call the...
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today...
UPDATE – IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 28, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 22, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...